A Study of an Experimental Drug for Treatment of Kids Hospitalized with COVID-19
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Summary
- Eligibility
- for people ages up to 17 years (full criteria)
- Location
- at Memphis, Tennessee and other locations
- Dates
- study startcompletion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- Sponsor
- Regeneron Pharmaceuticals
- Links
- Sign up for this study
- ID
- NCT05092581
- Phase
- Phase 1 COVID-19 Research Study
- Study Type
- Interventional
- Participants
- About 2 people participating
- Last Updated